Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Cubist_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2013
|
| gptkbp:focus |
antibiotic drug development
|
| gptkbp:founded |
2004
|
| gptkbp:headquarters_location |
gptkb:San_Diego,_California,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Jeffrey_Stein
|
| gptkbp:notableProduct |
gptkb:tedizolid
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:TSRX
|
| gptkbp:bfsParent |
gptkb:Sofinnova_Investments
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Trius Therapeutics
|